Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 14/20 | 0.81 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.81 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.56 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.56 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.56 |
| ▸ | GLP1R | P43220 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1245563 | 0.97 | SLC6A5 (0.85) | NOD1SLC6A5FOLH1ITGB3ITGA2B | |
| SCHEMBL9716727 | 0.97 | SLC6A5 (0.85) | NOD1SLC6A5FOLH1ITGB3ITGA2B | |
| SCHEMBL5946236 | 0.97 | SLC6A5 (0.85) | NOD1SLC6A5FOLH1ITGB3ITGA2B | |
| SCHEMBL1487710 | 0.97 | SLC6A5 (0.85) | NOD1SLC6A5FOLH1ITGB3ITGA2B | |
| SCHEMBL2166697 | 0.97 | SLC6A5 (0.85) | NOD1SLC6A5FOLH1ITGB3ITGA2B | |
| SCHEMBL15474 | 0.97 | SLC6A5 (0.85) | NOD1SLC6A5FOLH1ITGB3ITGA2B | |
| SCHEMBL1982744 | 0.97 | SLC6A5 (0.85) | NOD1SLC6A5FOLH1ITGB3ITGA2B | |
| SCHEMBL342965 | 0.97 | SLC6A5 (0.85) | NOD1SLC6A5FOLH1ITGB3ITGA2B | |
| SCHEMBL9716739 | 0.97 | SLC6A5 (0.85) | NOD1SLC6A5FOLH1ITGB3ITGA2B | |
| SCHEMBL343693 | 0.97 | SLC6A5 (0.85) | NOD1SLC6A5FOLH1ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030199672-A1 | Derivatives of GLP-1 analogs | KNUDSEN LISELOTTE BJERRE (DK) | 2003-10-23 | — | — | US | disclosed |
| US-20010011071-A1 | DERIVATIVES OF GLP-1 ANALOGS | KNUDSEN LISELOTTE BJERRE (DK) | 2001-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030199672-A1 | Derivatives of GLP-1 analogs | GLP1R, GIPR, IAPP | NOD1 707/4885SLC6A5 1057/4885FOLH1 681/4885 |
| US-20010011071-A1 | DERIVATIVES OF GLP-1 ANALOGS | GLP1R, GIPR, IAPP | NOD1 707/4885SLC6A5 1057/4885FOLH1 681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.